Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia? (IMAGE)

Regenstrief Institute

Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia?

Caption

Writing in JAMA Internal Medicine, Regenstrief Institute investigators Noll Campbell, Richard Holden and Malaz Boustani call for randomized deprescribing trials to address anticholinergic drug use as a potentially modifiable and reversible risk factor for dementia. The link between these drugs and cognitive impairment has been shown, they note, but is there a cause and effect relationship?

Credit

Regenstrief Institute

Usage Restrictions

Credit to Regenstrief Institute

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.